LENZ Therapeutics (NASDAQ:LENZ) Sees Strong Trading Volume – Here’s What Happened

Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ) saw unusually-strong trading volume on Wednesday . Approximately 119,272 shares were traded during trading, a decline of 18% from the previous session’s volume of 144,909 shares.The stock last traded at $23.30 and had previously closed at $22.97.

LENZ Therapeutics Trading Up 3.0 %

The stock’s fifty day simple moving average is $24.45 and its two-hundred day simple moving average is $26.95.

Hedge Funds Weigh In On LENZ Therapeutics

A number of hedge funds and other institutional investors have recently bought and sold shares of LENZ. GSA Capital Partners LLP bought a new stake in shares of LENZ Therapeutics in the 3rd quarter worth approximately $246,000. Charles Schwab Investment Management Inc. lifted its stake in LENZ Therapeutics by 197.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 123,371 shares of the company’s stock valued at $2,929,000 after buying an additional 81,901 shares during the last quarter. The Manufacturers Life Insurance Company acquired a new position in shares of LENZ Therapeutics during the third quarter valued at $743,000. MetLife Investment Management LLC bought a new position in shares of LENZ Therapeutics during the third quarter worth about $182,000. Finally, BBR Partners LLC increased its holdings in shares of LENZ Therapeutics by 100.0% in the 3rd quarter. BBR Partners LLC now owns 40,000 shares of the company’s stock worth $950,000 after acquiring an additional 20,000 shares during the period. 54.32% of the stock is currently owned by institutional investors and hedge funds.

LENZ Therapeutics Company Profile

LENZ Therapeutics, Inc, a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.